Biogen (NASDAQ:BIIB) Given New $199.00 Price Target at Truist Financial
Biogen (NASDAQ:BIIB – Free Report) had its target price decreased by Truist Financial from $210.00 to $199.00 in a research note issued to investors on Tuesday,Benzinga reports. Truist Financial currently has a buy rating on the biotechnology company’s stock. A number of other equities research analysts also recently commented on the stock. Scotiabank lowered their […]
Biogen (NASDAQ:BIIB – Free Report) had its target price decreased by Truist Financial from $210.00 to $199.00 in a research note issued to investors on Tuesday,Benzinga reports. Truist Financial currently has a buy rating on the biotechnology company’s stock. A number of other equities research analysts also recently commented on the stock. Scotiabank lowered their […]
